Compare VanEck JP Morgan EM Local Currency Bond ETF (EMLC) vs IDEXX Laboratories, Inc. (IDXX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
VanEck JP Morgan EM Local Currency Bond ETF vs IDEXX Laboratories, Inc. — how do they compare? VanEck JP Morgan EM Local Currency Bond ETF trades at $24.84 (market cap $4.93B), while IDEXX Laboratories, Inc. trades at $518 (market cap $40.43B). The key difference: IDEXX Laboratories, Inc. is far larger — about 8.2× VanEck JP Morgan EM Local Currency Bond ETF's market cap, and IDEXX Laboratories, Inc. is more actively traded (692,164 versus 2,843,860). Which is the better fit depends on your goals — on Pluang, investors hold VanEck JP Morgan EM Local Currency Bond ETF for 38 Days and IDEXX Laboratories, Inc. for 46 Days on average.
| EMLC | IDXX | |
|---|---|---|
Market Cap | $4.93B | $40.43B |
Volume | 2,843,860 | 692,164 |
Sector | Fixed Income | Health |
52-Week High | $26.59 | $766.68 |
52-Week Low | $24.53 | $504.70 |
Typical Hold Time | 38 Days | 46 Days |
Enterprise Value | — | $41.32B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EMLC trades at $24.78, showing minimal daily change. The technical outlook is bearish, with moving averages and ADX signaling a downtrend, while oscillators are neutral. Recent news highlights the ETF hitting a 52-week low amid a strengthening U.S. dollar, which pressures emerging market local currency bonds. No fundamental financial ratios are available in the provided data, limiting traditional valuation analysis.
The outlook remains cautious due to macroeconomic headwinds like dollar strength and potential Fed rate hikes. Risks include currency volatility and rising bond yields. Analyst sentiment appears bearish, with the ETF facing challenges in the near term, though diversification benefits in foreign bonds may offer long-term value if conditions stabilize.
IDEXX Laboratories (IDXX) trades at $513.14, up 1.28% with strong fundamentals including 25.03% net income margin and 74.21% ROE. The stock shows bearish technical signals but maintains consistent earnings beats and analyst consensus of $665 price target. Recent acquisition of CoVetAI expands AI capabilities in veterinary workflow intelligence, supporting long-term growth framework.
Outlook remains positive with revenue growth accelerating to $4.3B in 2025 and projected $4.6B in 2026. Key risks include foreign exchange headwinds and weaker U.S. veterinary visits. The 56.5% buy rating from analysts suggests continued confidence in the company's diagnostic innovation pipeline and recurring revenue economics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About VanEck JP Morgan EM Local Currency Bond ETF
EMLC invests in local currency-denominated government bonds from emerging market countries. It provides exposure to sovereign debt in nations like Brazil, Mexico, and South Africa, allowing investors to gain from high yields and potential local currency appreciation.
Read more on EMLC →About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →
